AstraZeneca has agreed to acquire Belgian in vivo cell therapy biotech EsoBiotec, strengthening its position in the emerging field of treatments that can reprogramme immune cells inside patients' ...

A first-in-human clinical trial of an immune rejuvenation therapy designed to restore the function of worn-out T cells is ...

Inside the labs and clinics where founders, physicians and researchers are betting their lives on 'solving' ageing. By Susan Stone of It's a Jungle. What if ageing isn’t inevitable? What if it’s just ...

aCenter for Stem Cell and Translational Immunotherapy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA bDepartment of Neurosurgery, Brigham and Women's Hospital, Harvard ...

Gout and hyperuricemia represent significant global health burdens, characterized by painful inflammatory arthritis and systemic metabolic dysfunction, respectively. Current pharmacological management ...

This new method is much easier to programme than the conventional approach and is available at a fraction of the cost, according to experts in the field. The treatment, known as CAR-T, is a type of ...

The most important change was a more bespoke interior, along with a power boost from new injectors, a revised ECU and cylinder heads, plus forged conrods. Firmer suspension with a 5mm lower ride ...

Follow MCN on Google Add MCN as a preferred source on Google to see more of our latest content ...

The two new Centres will build on the huge progress that has been made in genomics – allowing the genetic basis of many diseases and processes to be identified – and advances in genome editing and ...

Chinese scientists have reported the world’s first case of using cell transplants to treat type 1 diabetes. The patient, a 25-year-old who had the chronic condition for over a decade, was able to ...